⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBIO News
iBio, Inc. Common Stock
Form 8-K
sec.gov
IBIO
iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
globenewswire.com
IBIO
ACTG to Make Three Presentations on HIV Cure and Aging with HIV at AIDS 2026
globenewswire.com
IBIO
GILD
Form 8-K
sec.gov
IBIO
Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
prnewswire.com
PFE
ABBV
RMD
GSK
AZN
BNTX
INCY
IOVA
RGEN
MRK
LLY
IBIO
GILD
AMGN
JNJ
NVS
RIGL
BIIB
Form 8-K
sec.gov
IBIO
iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
globenewswire.com
IBIO
Breakthrough Immorta Bio Study Collaboration With TAM Global Increases Life Span In Mice over 70% Using Novel Combination Senolytics
prnewswire.com
IBIO
iBio to Participate in Upcoming Healthcare Investor Conferences
globenewswire.com
IBIO
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
globenewswire.com
IBIO